BioMarin Pharmaceutical Inc. (FRA:BM8)
Germany · Delayed Price · Currency is EUR 47.62
0.00 (0.00%)
At close: Nov 28, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of €9.09 billion as of December 1, 2025. Its market cap has decreased by -24.30% in one year.
Market Cap
9.09B
Enterprise Value
8.34B
Revenue
2.64B
Ranking
n/a
PE Ratio
20.50
Stock Price
€47.62
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 9.09B, an increase of 2,036.66%. That is a compound annual growth rate of 12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 9.09B | -24.84% |
| Dec 31, 2024 | 12.10B | -26.36% |
| Dec 29, 2023 | 16.43B | -8.70% |
| Dec 30, 2022 | 18.00B | 26.18% |
| Dec 31, 2021 | 14.26B | 9.60% |
| Dec 31, 2020 | 13.01B | -3.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |